Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 3 » Issue 1

The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction

Authors Ling W, Farabee D, Liepa D, Wu LT

Published Date December 2012 Volume 2012:3(1) Pages 129—136

DOI http://dx.doi.org/10.2147/SAR.S38902

Received 7 October 2012, Accepted 31 October 2012, Published 6 December 2012

Walter Ling,1 David Farabee,1 Dagmar Liepa,2 Li-Tzy Wu3

1
Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA; 2Valley Care Medical Center, Panorama City, CA, USA; 3Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Durham, NC, USA

Abstract: The fields of addiction medicine and addiction research have long sought an efficient yet comprehensive instrument to assess patient progress in treatment and recovery. Traditional tools are expensive, time consuming, complex, and based on topics that clinicians or researchers think are important. Thus, they typically do not provide patient-centered information that is meaningful and relevant to the lives of patients with substance use disorders. To improve our ability to understand patients’ progress in treatment from their perspectives, the authors and colleagues developed a patient-oriented assessment instrument that has considerable advantages over existing instruments: brevity, simplicity, ease of administration, orientation to the patient, and cost (none). The resulting Treatment Effectiveness Assessment (TEA) elicits patient responses that help the patient and the clinician quickly gauge patient progress in treatment and in recovery, according to the patients’ sense of what is important within four domains established by prior research. Patients provide both numerical responses and representative details on their substance use, health, lifestyle, and community. No software is required for data entry or scoring, and no formal training is required to administer the TEA. This article describes the development of the TEA and the initial phases of its application in clinical practice and in research.

Keywords: substance use disorders, global treatment progress, brief instrument, patient-centered

A Letter to the Editor has been received and published for this article.

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The Treatment Effectiveness Assessment (TEA)

Ling W, Farabee D, Liepa D, Wu LT

Substance Abuse and Rehabilitation 2013, 4:73-74

Published Date: 24 September 2013

Readers of this article also read:

Effects of different doses of testosterone on gonadotropins, 25-hydroxyvitamin D3, and blood lipids in healthy men

Gårevik N, Rane A, Björkhem-Bergman L, Ekström L

Substance Abuse and Rehabilitation 2014, 5:121-127

Published Date: 10 December 2014

Posttraumatic stress symptoms, dissociation, and alexithymia in an Italian sample of flood victims

Craparo G, Gori A, Mazzola E, Petruccelli I, Pellerone M, Rotondo G

Neuropsychiatric Disease and Treatment 2014, 10:2281-2284

Published Date: 28 November 2014

Abuse and misuse of antidepressants

Evans EA, Sullivan MA

Substance Abuse and Rehabilitation 2014, 5:107-120

Published Date: 14 August 2014

Nalmefene: a new approach to the treatment of alcohol dependence

Paille F, Martini H

Substance Abuse and Rehabilitation 2014, 5:87-94

Published Date: 8 August 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:1333-1334

Published Date: 18 July 2014

Proposed criteria for schizophrenia remission

AlAqeel B

Neuropsychiatric Disease and Treatment 2014, 10:619-623

Published Date: 16 April 2014

Monoamine depletion by reuptake inhibitors

Hinz M, Stein A, Uncini T

Drug, Healthcare and Patient Safety 2011, 3:69-77

Published Date: 20 October 2011